Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-30,047
Closed -$1.01M 90
2022
Q4
$1.01M Buy
30,047
+285
+1% +$9.37K 0.65% 54
2022
Q3
$902K Buy
29,762
+7,914
+36% +$328K 0.63% 57
2022
Q2
$876K Buy
21,848
+964
+5% +$45.5K 0.58% 56
2022
Q1
$1M Buy
20,884
+1,992
+11% +$103K 0.57% 58
2021
Q4
$1.06M Buy
18,892
+2,392
+14% +$131K 0.58% 59
2021
Q3
$765K Buy
16,500
+4,438
+37% +$213K 0.45% 67
2021
Q2
$593K Buy
12,062
+563
+5% +$28.5K 0.35% 75
2021
Q1
$544K Buy
11,499
+2,555
+29% +$114K 0.35% 73
2020
Q4
$360K Buy
+8,944
New +$315K 0.25% 87

Other funds holding AVNT

Red Spruce Capital's AVNT Position: Q1 2023 in Review

Red Spruce Capital sold out of Avient (AVNT) in Q1 2023, closing a stake of 30,047 shares — an estimated $1.01M sold.

Red Spruce Capital first reported a position in AVNT in Q4 2020 and held it in 9 quarters. The position peaked at $1.06M in Q4 2021. 262 funds tracked by Wall St. Rank hold AVNT as of Q1 2023.

  • Red Spruce Capital reported no remaining Avient position as of Q1 2023 after selling out during the quarter.
  • Red Spruce Capital sold 30,047 Avient shares in Q1 2023, an estimated $1.01M.
  • Red Spruce Capital first reported a position in Avient in Q4 2020 and held it in 9 quarters.
  • Red Spruce Capital's Avient position peaked at $1.06M in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Avient as of Q1 2023.

Based on Red Spruce Capital's 13F filing for Q1 2023, filed 6 Apr 2023.